David M. Hume Memorial Lecture. An overview of the stroke problem in the carotid territory
Insights
Carotid endarterectomy effectively treats transient ischemic attacks (TIAs) with low mortality. However, cardiac disease remains a significant risk, and antiplatelet agents offer limited stroke protection.
Area of Science:
- Vascular Surgery
- Neurology
- Cardiology
Background:
- Carotid artery atherosclerosis is a significant risk factor for stroke.
- Transient ischemic attacks (TIAs) are warning signs of potential stroke.
- Carotid endarterectomy is a surgical procedure to remove plaque from the carotid artery.
Purpose of the Study:
- To evaluate the long-term outcomes of carotid endarterectomy.
- To identify the primary risks and benefits associated with the procedure.
- To assess the role of antiplatelet agents in preventing stroke.
Main Methods:
- Review of 1,000 carotid endarterectomies over a 20-year period.
- Analysis of patient outcomes, including TIA relief, operative mortality, and recurrent stenosis.
- Evaluation of intraoperative monitoring techniques like continuous electroencephalographic monitoring.
- Assessment of coexisting cardiac disease as an operative hazard.
Main Results:
- Approximately 85% of patients experienced relief from TIAs.
- Operative mortality was 1.3%, primarily due to myocardial infarction.
- Recurrent stenosis rate was 3.1%.
- Coexisting cardiac disease was identified as the main operative hazard.
- Continuous electroencephalographic monitoring proved reliable for detecting cerebral hypoperfusion.
- Prophylactic carotid endarterectomy demonstrated minimal mortality and morbidity.
- Antiplatelet agents showed efficacy in reducing TIAs but limited protection against stroke.
Conclusions:
- Carotid endarterectomy is a safe and effective procedure for TIA patients.
- Managing cardiac comorbidities is crucial for reducing operative risks.
- Continuous electroencephalographic monitoring aids in surgical safety.
- Atherosclerotic plaques in the carotid artery require intervention.
- Antiplatelet therapy alone is insufficient for comprehensive stroke prevention.
Abstract:
In a review of 1,000 carotid endarterectomies performed over a 20 year period, there was relief of transient ischemic attacks in approximately 85% of patients, an operative mortality of 1.3%, due almost exclusively to myocardial infarction, and a recurrent stenosis rate of 3.1%. Coexisting cardiac disease constitutes the greatest operative hazard. Continuous electroencephalographic monitoring is a reliable method of detecting inadequate cerebral perfusion during carotid cross clamping and for the selective use of a temporary inlying carotid shunt. An atherosclerotic plaque in the carotid system constitutes a greater risk than elsewhere in the peripheral arterial system and should not be considered an innocent lesion. Prophylactic carotid endarterectomy can be performed with almost no mortality and morbidity. Antiplatelet agents, while useful in reducing the incidence of transient ischemic attacks, do not seem to provide equal protection against stroke and death from stroke.
More Related Videos
07:26Modeling Stroke in Mice: Transient Middle Cerebral Artery Occlusion via the External Carotid Artery
Published on: May 24, 2021
09:36A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis
Published on: August 12, 2025
Related Concept Videos
Arteries of the Head and Neck
The internal carotid arteries supply blood to the anterior portion of the cerebrum. They enter the...
Stroke: Introduction and Types
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
